- Sulfonyl Ureas
- Di Peptidyl Peptidase (DPP)-IV Inhibitors
- ?-glucosidase Inhibitos
- GLP-1 Agonists
Biosimilars are biological substances that are highly similar to biologics but not identical with patented biological molecules. These are manufactured after the patent expiration of original products. Anti-diabetic biosimilars are help to control the blood glucose levels in the diabetic patients. Commonly used anti-diabetic drugs include biguanides, sulfonyl ureas, GLP-1 receptor agonists, DPP-IV inhibitors, thiazolidinediones, and insulin among others. These are cost-effective molecules with similar potency and efficiency compared with reference biologic molecules.Asia Pacific Anti diabetic Biosimilars Market report gives a comprehensive outlook across the regions with special emphasis on key countries such as Australia, China, India, Japan, Indonesia, Vietnam, South Korea, and Rest of APAC. The report gives historical, current, and future market sizes (US$ Mn) on the basis of drug class, disease type, distribution channel and countries. This report studies Asia Pacific Antidiabetic Biosimilars Market dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the countries and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers..
Fastest Growing Market
Increase in the prevalence of diabetes majorly in China and India, Patent expiries of block buster drugs and promising product pipeline and Rise in R&D activities for the innovation of Insulin biosimilars
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.